US · Healthcare · Medical Care Facilities
EPS came in at -0.63 against a street estimate of -1.89 — a beat of 66.7%.
Analysts rate P3 Health Partners Inc a buy (1 buy, 1 hold, 0 sell out of 2) with an average price target of $18.00.
| Fund | Stake |
|---|---|
| HRT FINANCIAL LLC | 1.40% |
| Jane Street Group LLC | 1.39% |
| Vanguard Capital Management, LLC | 1.06% |
| MYDA Advisors LLC | 0.51% |
| CI Private Wealth LLC | 0.50% |
| Geode Capital Management, LLC | 0.44% |
| Scientech Research LLC | 0.42% |
| Abundance Wealth Counselors | 0.41% |
| Document | Date |
|---|---|
| Material agreement · Q3 2026 P3 HEALTH PARTNERS INC. (PIII) – FORM 8-K SUMMARY HEADLINE NUMBERS • Company secured up to $70 million in funding through Securities Purchase Agreem | 2026-09-11 |
| Quarterly report · Q2 2026 P3 HEALTH PARTNERS INC. — Q2 2026 FORM 10-Q SUMMARY --- HEADLINE NUMBERS • Total assets: $654.4 million (June 30, 2026) vs. $656.6 million (Decembe | 2026-08-10 |
| Results announced · Q3 2026 P3 HEALTH PARTNERS INC. – Q2 2026 RESULTS SUMMARY --- HEADLINE NUMBERS • Q2 2026 At-Risk Members: 105,000 (down 10% year-over-year due to intention | 2026-08-10 |
| Material agreement · Q2 2026 P3 HEALTH PARTNERS INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Debt Maturity Extension: Repurchase Promissory Note maturity date extended to Septembe | 2026-07-06 |
| Shareholder vote results · Q2 2026 P3 HEALTH PARTNERS INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Stockholders held June 9, 2026 • Company trades on NASDAQ under symb | 2026-06-10 |
| Current report · Q2 2026 P3 HEALTH PARTNERS INC. - DOCUMENT SUMMARY HEADLINE NUMBERS • Company: P3 Health Partners Inc. (Nasdaq ticker: PIII) • Headquarters: 2370 Corporate | 2026-05-26 |
| Quarterly report · Q1 2026 P3 HEALTH PARTNERS INC. — Q1 2026 FORM 10-Q SUMMARY HEADLINE NUMBERS • Q1 2026 total operating revenue: $386.4 million (up from $373.2 million in Q1 | 2026-05-14 |
| Proxy statement · Q2 2026 P3 HEALTH PARTNERS INC. — PROXY STATEMENT SUMMARY CEO COMPENSATION • Aric Coffman, M.D. (CEO) total 2025 compensation: Not specified in provided doc | 2026-04-30 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for P3 Health Partners Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.